About Kreit Pharma Private Limited
Data last updated:
Kreit Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51502MH2014PTC258223. Its GSTIN is 27AAFCK6394R1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kandiga Vinod Reddy and Krishnaveni Vinod Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 201 Floor 2 Plot 1 F Wing Indira Nagar Chs L Gtb Nagar Sion Koliwada Antop Hill, Mumbai, Maharashtra, India – 400037.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.33 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹97,753 (net margin 2.7%) and EBITDA of ₹2.08 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website kreitpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF – 201 Floor 2 Plot 1 F Wing Indira Nagar Chs L Gtb Nagar Sion Koliwada Antop Hill, Mumbai, Maharashtra, India – 400037
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kreit Pharma Private Limited
The main business activity of Kreit Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kreit Pharma Private Limited FY 2025 filings available
Kreit Pharma Private Limited reported revenue of ₹36.33 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kreit Pharma Private Limited
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 146% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kreit Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.08 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹97,753 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kreit Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kreit Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kreit Pharma Private Limited
Kreit Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zdravi Duvera India Limited | ₹36.53 Lakh (FY 2018) | •••• | •••• | -42.0% | •••• | Navi Mumbai, Maharashtra, India |
| Prikshit Dairies Private Limited | ₹36.45 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Pathankot, Punjab, India |
| Rmanirex Pharma Private Limited | ₹36.41 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Andhra Agro-Vet Associates Private Limited | ₹36.4 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Hyderabad, Telangana, India |
| Ads Lifescience Private Limited | ₹36.37 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Patna, Bihar, India |
| Kreit Pharma Private Limited this company | ₹36.33 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Melrose Healthcare Private Limited | ₹36.27 Lakh (FY 2021) | •••• | •••• | -36.0% | •••• | Chennai, Tamil Nadu, India |
| Livochem Pharma Private Limited | ₹36.22 Lakh (FY 2024) | •••• | •••• | 9.0% | •••• | Moradabad, Uttar Pradesh, India |
| BRS Mercantiles Private Limited | ₹36.11 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Gurgaon, Haryana, India |
| Norvik Pharmaceuticals Private Limited | ₹36.03 Lakh (FY 2020) | •••• | •••• | 15.0% | •••• | Bangalore, Karnataka, India |
| Samesia Biotech Private Limited | ₹35.97 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Kreit Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kreit Pharma Private Limited
Auditor information for Kreit Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Kreit Pharma Private Limited
Kreit Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kandiga Vinod Reddy | Director | 19 Sep 2014 | 12 Years 0 Months | Current |
| Krishnaveni Vinod Reddy | Director | 19 Sep 2014 | 12 Years 0 Months | Current |
Ownership and Shareholding of Kreit Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kreit Pharma Private Limited
Kreit Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kreit Pharma Private Limited
Employment history and EPFO contributions of people linked to Kreit Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kreit Pharma Private Limited
Kreit Pharma Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Kandiga Vinod Reddy was appointed as Director on 19 Sep 2014.
Credit Ratings, Litigation & Regulatory Alerts for Kreit Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kreit Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kreit Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kreit Pharma Private Limited
Kreit Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCK6394R1ZJ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kreit Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kreit Pharma Private Limited
Kreit Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 September 2014 (12+ years old) and is registered under CIN U51502MH2014PTC258223.
Kreit Pharma reported revenue of ₹36.33 Lakh for FY 2025 (down 2% YoY).
Kreit Pharma has 2 current directors:
- Kandiga Vinod Reddy - Director
- Krishnaveni Vinod Reddy - Director
Kreit Pharma reported a net profit of ₹97,753 (net margin 2.7%) and EBITDA of ₹2.08 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kreit Pharma is 14% over three years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kreit Pharma is 27AAFCK6394R1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kreit Pharma is U51502MH2014PTC258223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kreit Pharma was incorporated on 19 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kreit Pharma by revenue are Zdravi Duvera India Limited, Prikshit Dairies Private Limited, Rmanirex Pharma Private Limited, Andhra Agro-Vet Associates Private Limited, Ads Lifescience Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Kandiga Vinod Reddy was appointed as Director on 19 Sep 2014. Krishnaveni Vinod Reddy was appointed as Director on 19 Sep 2014.
Kreit Pharma can be reached through the website kreitpharma.com. Its registered office is in Mumbai, Maharashtra, India.